P -values < 0.05 were considered significant (*), those < 0.01 very significant (**), and those < 0.001 extremely significant (***).
← all excerpts
The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy.
1
—
—